
A novel program utilizing an approach to defragment care for patients with end-stage kidney disease (ESKD) resulted in better patient outcomes.
A novel program utilizing an approach to defragment care for patients with end-stage kidney disease (ESKD) resulted in better patient outcomes.
This article provides an overview of the impact of specialty care and the opportunity for it to leapfrog primary care as a lead focus for accountable care.
A report on the clinical and economic outcomes of a new payer–provider partnership serving patients with end-stage renal disease.
Published: May 13th 2024 | Updated:
Published: April 16th 2018 | Updated:
Published: September 18th 2019 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.